Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety.
Lamivudine has been demonstrated safe and efficacious in the short term in a large cohort of children with chronic hepatitis B (CHB), but optimal duration of treatment has not been elucidated and limited data on the safety of long-term lamivudine administration have been reported. In addition, the d...
| Autor principal: | |
|---|---|
| Outros Autores: | , , , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2014
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10400.10/1129 |
| País: | Portugal |
| Oai: | oai:repositorio.hff.min-saude.pt:10400.10/1129 |